In silico methodology is discussed as a comprehensive approach to studying squamous cell carcinoma (SCC) and oral squamous cell carcinoma (OSCC). The advancement of computational methodologies has enabled the discovery of novel biomarkers by enhancing our understanding of tumor biology. In this chapter, we explore how bioinformatics tools improve our knowledge of the molecular mechanisms underlying these diseases and contribute to potential therapeutic advancements. Cancer research has been revolutionized through the integration of computational techniques, facilitating the identification of biomarkers and improving our understanding of tumor progression. By combining genomic, transcriptomic, and proteomic datasets, bioinformaticians enable researchers to uncover key pathways involved in disease development, drug resistance, and interactions within the tumor microenvironment. This chapter discusses various computational techniques, including gene expression analysis, network-based modeling, and machine learning algorithms, which aid in identifying prognostic and diagnostic markers. Additionally, we highlight the significance of publicly available datasets and high-throughput sequencing technologies in advancing in silico analysis. The utilization of bioinformatics bridges the gap between basic research and clinical applications, paving the way for more personalized treatment strategies. By emphasizing the role of in silico methodologies, this chapter demonstrates how these approaches contribute to precision medicine. Advancing our understanding of the molecular mechanisms of SCC and OSCC facilitates the development of targeted therapeutics, ultimately leading to improved patient outcomes.